InsiderClue
Stocks · Health care · Services-Misc Health & Allied Services, NEC

CRYO CELL INTERNATIONAL INC

CCEL Clue Score29
United States Fiscal year ends November CIK 0000862692
$4.36 +4.56% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $4.36 −64.23% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue23.1Operating income0.4Net income−1.3EPS, diluted−0.16Fiscal year 2017Revenue25.4 +9.8%Operating income5.0Net income2.3EPS, diluted0.30Fiscal year 2018Revenue29.2 +15.1%Operating income5.2Net income−0.9 −136.9%EPS, diluted−0.11 −136.7%Fiscal year 2019Revenue31.8 +8.9%Operating income5.1Net income2.3EPS, diluted0.27Fiscal year 2020Revenue31.1 −2.1%Operating income7.7Net income3.6 +58.2%EPS, diluted0.45 +66.7%Fiscal year 2021Revenue28.9 −7.3%Operating income4.0Net income2.1 −42.5%EPS, diluted0.25 −44.4%Fiscal year 2022Revenue30.3 +5.0%Operating income4.0Net income2.8 +33.0%EPS, diluted0.33 +32.0%Fiscal year 2023Revenue31.3 +3.3%Operating income−12.3Net income−9.5 −443.6%EPS, diluted−1.14 −445.5%Fiscal year 2024Revenue32.0 +2.0%Operating income3.5Net income0.4EPS, diluted0.05Fiscal year 2025Revenue31.6 −1.3%Operating income0.5Net income−2.4 −704.2%EPS, diluted−0.30 −700.0%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 23.1 25.4 29.2 31.8 31.1 28.9 30.3 31.3 32.0 31.6
Growth +9.8% +15.1% +8.9% −2.1% −7.3% +5.0% +3.3% +2.0% −1.3%
Operating income 0.4 5.0 5.2 5.1 7.7 4.0 4.0 −12.3 3.5 0.5
Net income −1.3 2.3 −0.9 2.3 3.6 2.1 2.8 −9.5 0.4 −2.4
Growth −136.9% +58.2% −42.5% +33.0% −443.6% −704.2%
EPS, diluted −0.16 0.30 −0.11 0.27 0.45 0.25 0.33 −1.14 0.05 −0.30
Growth −136.7% +66.7% −44.4% +32.0% −445.5% −700.0%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Operating margin1.9%Net margin−5.7%Free cash flow margin20.1%Fiscal year 2017Operating margin19.7%Net margin9.1%Free cash flow margin22.1%Fiscal year 2018Operating margin17.8%Net margin−2.9%Free cash flow margin16.7%Fiscal year 2019Operating margin15.9%Net margin7.2%Free cash flow margin17.7%Fiscal year 2020Operating margin24.6%Net margin11.6%Free cash flow margin26.9%Fiscal year 2021Operating margin13.9%Net margin7.2%Free cash flow margin21.1%Fiscal year 2022Operating margin13.3%Net margin9.1%Free cash flow margin−11.9%Fiscal year 2023Operating margin−39.3%Net margin−30.4%Free cash flow margin6.6%Fiscal year 2024Operating margin10.9%Net margin1.3%Free cash flow margin11.3%Fiscal year 2025Operating margin1.5%Net margin−7.7%Free cash flow margin16.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin 1.9% 19.7% 17.8% 15.9% 24.6% 13.9% 13.3% −39.3% 10.9% 1.5%
Net margin −5.7% 9.1% −2.9% 7.2% 11.6% 7.2% 9.1% −30.4% 1.3% −7.7%
Free cash flow margin 20.1% 22.1% 16.7% 17.7% 26.9% 21.1% −11.9% 6.6% 11.3% 16.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow5.0Capital expenditure−0.3Free cash flow4.6Buybacks−10.8Fiscal year 2017Operating cash flow5.7Capital expenditure−0.1Free cash flow5.6 +21.0%Buybacks−0.4Fiscal year 2018Operating cash flow5.3Capital expenditure−0.4Free cash flow4.9 −13.0%Fiscal year 2019Operating cash flow6.3Capital expenditure−0.7Free cash flow5.6 +15.3%Buybacks−1.0Fiscal year 2020Operating cash flow8.5Capital expenditure−0.1Free cash flow8.4 +48.5%Fiscal year 2021Operating cash flow7.9Capital expenditure−1.8Free cash flow6.1 −27.2%Buybacks−0.2Dividends paid0.0Fiscal year 2022Operating cash flow8.6Capital expenditure−12.2Free cash flow−3.6 −159.0%Buybacks−1.8Dividends paid−7.7Fiscal year 2023Operating cash flow8.9Capital expenditure−6.8Free cash flow2.1Buybacks−0.8Dividends paid0.0Fiscal year 2024Operating cash flow6.0Capital expenditure−2.4Free cash flow3.6 +73.4%Buybacks−1.4Dividends paid−2.0Fiscal year 2025Operating cash flow5.5Capital expenditure−0.2Free cash flow5.2 +45.5%Buybacks−0.2Dividends paid−3.2
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow 5.0 5.7 5.3 6.3 8.5 7.9 8.6 8.9 6.0 5.5
Capital expenditure −0.3 −0.1 −0.4 −0.7 −0.1 −1.8 −12.2 −6.8 −2.4 −0.2
Free cash flow 4.6 5.6 4.9 5.6 8.4 6.1 −3.6 2.1 3.6 5.2
Growth +21.0% −13.0% +15.3% +48.5% −27.2% −159.0% +73.4% +45.5%
Buybacks −10.8 −0.4 n/a −1.0 n/a −0.2 −1.8 −0.8 −1.4 −0.2
Dividends paid n/a n/a n/a n/a n/a 0.0 −7.7 0.0 −2.0 −3.2

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash3.5Total debt1.4Net cash (debt)2.1Shareholders’ equity−15.4Fiscal year 2017Cash6.3Total debt1.4Net cash (debt)4.9Shareholders’ equity−12.5Fiscal year 2018Cash6.0Total debt1.4Net cash (debt)4.6Shareholders’ equity−8.9Fiscal year 2019Cash6.5Total debt9.0Net cash (debt)−2.4Shareholders’ equity−7.0Fiscal year 2020Cash10.4Total debt5.9Net cash (debt)4.4Shareholders’ equity−2.7Fiscal year 2021Cash8.3Total debt1.9Net cash (debt)6.4Shareholders’ equity4.2Debt to equity0.45Fiscal year 2022Cash1.7Total debt8.7Net cash (debt)−7.0Shareholders’ equity−1.5Fiscal year 2023Cash0.4Total debt8.6Net cash (debt)−8.2Shareholders’ equity−11.0Fiscal year 2024Cash0.6Total debt8.5Net cash (debt)−7.9Shareholders’ equity−13.2Fiscal year 2025Cash0.3Total debt8.4Net cash (debt)−8.0Shareholders’ equity−18.6
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 3.5 6.3 6.0 6.5 10.4 8.3 1.7 0.4 0.6 0.3
Total debt 1.4 1.4 1.4 9.0 5.9 1.9 8.7 8.6 8.5 8.4
Net cash (debt) 2.1 4.9 4.6 −2.4 4.4 6.4 −7.0 −8.2 −7.9 −8.0
Shareholders’ equity −15.4 −12.5 −8.9 −7.0 −2.7 4.2 −1.5 −11.0 −13.2 −18.6
Debt to equity n/a n/a n/a n/a n/a 0.45 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending November, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2010 30 Nov 2010 FY2011 30 Nov 2011 FY2012 30 Nov 2012 FY2013 30 Nov 2013 FY2014 30 Nov 2014 FY2015 30 Nov 2015 FY2016 30 Nov 2016 FY2017 30 Nov 2017 FY2018 30 Nov 2018 FY2019 30 Nov 2019 FY2020 30 Nov 2020 FY2021 30 Nov 2021 FY2022 30 Nov 2022 FY2023 30 Nov 2023 FY2024 30 Nov 2024 FY2025 30 Nov 2025
Assets
8.4 6.3 2.7 3.9 3.3 4.2 3.5 6.3 6.0 6.5 10.4 8.3 1.7 0.4 0.6 0.3
2.4 3.1 2.8 3.3 4.1 3.1 4.1 5.1 5.9 6.1 6.3 5.3 6.0 6.6 7.3 6.8
n/a n/a n/a n/a 0.1 0.5 0.4 0.3 1.3 1.1 0.9 0.9 0.9 0.8 0.7 0.4
2.2 1.5 1.3 1.2 1.0 0.9 1.0 0.9 1.5 1.8 1.6 3.2 13.6 21.0 21.9 21.0
n/a n/a n/a n/a 0.0 1.8 0.0 0.0 1.9 1.9 1.9 1.9 1.9 1.9 1.9 1.9
18.1 19.5 12.3 11.5 10.2 19.5 19.5 23.9 42.4 42.9 46.2 60.7 64.9 61.2 64.7 61.7
Growth +7.6% −36.7% −6.7% −11.2% +91.0% +0.2% +22.4% +77.3% +1.2% +7.7% +31.3% +7.0% −5.7% +5.6% −4.6%
Liabilities
3.8 2.9 2.3 2.3 2.3 2.3 1.4 1.4 1.4 9.0 5.9 1.9 8.7 8.6 8.5 8.4
calc 3.8 2.9 2.3 2.3 2.3 2.3 1.4 1.4 1.4 9.0 5.9 1.9 8.7 8.6 8.5 8.4
n/a n/a n/a n/a n/a 24.5 35.0 36.4 51.3 49.8 48.9 56.5 66.4 72.3 77.9 80.3
Equity
−25.3 −27.4 −33.8 −33.7 −33.6 −25.5 −26.8 −24.5 −25.3 −22.4 −18.8 −16.7 −21.6 −31.2 −32.8 −38.4
−1.0 −2.5 −9.0 −9.3 −10.7 −5.0 −15.4 −12.5 −8.9 −7.0 −2.7 4.2 −1.5 −11.0 −13.2 −18.6
Growth −136.4%
Per share and net cash
calc 4.6 3.5 0.4 1.6 1.0 1.9 2.1 4.9 4.6 −2.4 4.4 6.4 −7.0 −8.2 −7.9 −8.0
11.8 11.9 11.1 10.7 9.7 9.0 6.8 7.1 7.8 7.5 7.5 8.6 8.5 8.3 8.1 8.1
calc −0.09 −0.21 −0.81 −0.86 −1.11 −0.55 −2.27 −1.76 −1.14 −0.93 −0.35 0.49 −0.18 −1.33 −1.64 −2.31

Lines marked calc are worked out here from filed figures; point at one for how.